Showing results (11-20 of 128) with videos related to
Sort By:
Pageof 13
Current Treatment Options in Oncology|February 8, 2008
The emerging role of anti-angiogenic therapy for malignant gliomaDavid A Reardon, Annick Desjardins, Jeremy N Rich, et al.Journal of Magnetic Resonance Imaging : JMRI|April 24, 2009
Repeatability of quantitative parameters derived from diffusion tensor imaging in patients with glioblastoma multiformeMichael J Paldino, Daniel Barboriak, Annick Desjardins, et al.Expert Opinion on Biological Therapy|March 21, 2008
Glioblastoma multiforme: an emerging paradigm of anti-VEGF therapyDavid A Reardon, Patrick Y Wen, Annick Desjardins, et al.Therapeutics and Clinical Risk Management|May 14, 2008
Interstitial chemotherapy with biodegradable BCNU (Gliadel) wafers in the treatment of malignant gliomasDaniela A Bota, Annick Desjardins, Jennifer A Quinn, et al.Cancer|May 24, 2007
Molecularly targeted therapy for malignant gliomaSith Sathornsumetee, David A Reardon, Annick Desjardins, et al.Journal of Neuro-Oncology|June 5, 2010
Ulceration of Striae distensae in high-grade glioma patients on concurrent systemic corticosteroid and bevacizumab therapyKatherine B Peters, Thomas E Coyle, James J Vredenburgh, et al.Expert Opinion on Pharmacotherapy|August 3, 2011
Everolimus tablets for patients with subependymal giant cell astrocytomaScott G Turner, Katherine B Peters, James J Vredenburgh, et al.Neuro-Oncology|December 19, 2015
Marizomib activity as a single agent in malignant gliomas: ability to cross the blood-brain barrierKaijun Di, G Kenneth Lloyd, Vivek Abraham, et al.Journal of Neuro-Oncology|November 4, 2011
A phase II study of the Ras-MAPK signaling pathway inhibitor TLN-4601 in patients with glioblastoma at first progressionWarren P Mason, Karl Belanger, Garth Nicholas, et al.Cancer|November 21, 2015
Phase 1 dose escalation trial of the safety and pharmacokinetics of cabozantinib concurrent with temozolomide and radiotherapy or temozolomide after radiotherapy in newly diagnosed patients with high-grade gliomasDavid Schiff, Annick Desjardins, Timothy Cloughesy, et al.Pageof 13